Cancer Management and Research
Volume 11, 2019 - Issue
Original Research
Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway
Zhaohong Wang1 Department of Hepatobiliary Surgery, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou325000, People’s Republic of China;2 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou325000, People’s Republic of China
https://orcid.org/0000-0002-9958-4944
https://orcid.org/0000-0002-9958-4944, , , Zhong Hong1 Department of Hepatobiliary Surgery, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou325000, People’s Republic of Chinahttps://orcid.org/0000-0002-5825-0569
https://orcid.org/0000-0002-5825-0569, Yi Liao1 Department of Hepatobiliary Surgery, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou325000, People’s Republic of Chinahttps://orcid.org/0000-0002-7307-0830
https://orcid.org/0000-0002-7307-0830, & show all